NASDAQ:COCH Envoy Medical (COCH) Stock Price, News & Analysis $1.48 +0.06 (+3.87%) As of 10:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Envoy Medical Stock (NASDAQ:COCH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Envoy Medical alerts:Sign Up Key Stats Today's Range$1.40▼$1.5250-Day Range$1.36▼$1.7252-Week Range$1.21▼$3.99Volume10,996 shsAverage Volume80,283 shsMarket Capitalization$31.46 millionP/E RatioN/ADividend YieldN/APrice Target$9.25Consensus RatingBuy Company OverviewEnvoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.Read More… Envoy Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks56th Percentile Overall ScoreCOCH MarketRank™: Envoy Medical scored higher than 56% of companies evaluated by MarketBeat, and ranked 495th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingEnvoy Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageEnvoy Medical has only been the subject of 1 research reports in the past 90 days.Read more about Envoy Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Envoy Medical are expected to decrease in the coming year, from ($1.21) to ($1.23) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Envoy Medical is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Envoy Medical is -1.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Envoy Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted1.04% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in Envoy Medical has recently increased by 4.77%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEnvoy Medical does not currently pay a dividend.Dividend GrowthEnvoy Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.04% of the float of Envoy Medical has been sold short.Short Interest Ratio / Days to CoverEnvoy Medical has a short interest ratio ("days to cover") of 5.1.Change versus previous monthShort interest in Envoy Medical has recently increased by 4.77%, indicating that investor sentiment is decreasing. News and Social Media3.1 / 5News Sentiment0.65 News SentimentEnvoy Medical has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.90 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Envoy Medical this week, compared to 0 articles on an average week.Search Interest1 people have searched for COCH on MarketBeat in the last 30 days. MarketBeat Follows2 people have added Envoy Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Envoy Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $82,430.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders58.90% of the stock of Envoy Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.59% of the stock of Envoy Medical is held by institutions.Read more about Envoy Medical's insider trading history. Receive COCH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Envoy Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address COCH Stock News HeadlinesEnvoy Medical, Inc.: Envoy Medical Expands Global Patent Portfolio with New Issuances in Australia1 hour ago | finanznachrichten.deEnvoy Medical, Inc.: New CPT Codes for Totally Implantable Active Middle Ear Hearing Implants Go into Effect July 1, Unlocking New Opportunities for ... - FinanzNachrichten.deJune 27, 2025 | finanznachrichten.deTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…July 1 at 2:00 AM | Crypto 101 Media (Ad)Envoy Medical, Inc. (COCH) - Yahoo FinanceJune 27, 2025 | nz.finance.yahoo.comEnvoy Medical appoints Robert Potashnick as interim chief financial officerJune 27, 2025 | uk.investing.comEnvoy Medical to Present at the Life Sciences Virtual Investor Forum June 12thJune 11, 2025 | globenewswire.comEnvoy Medical advances in cochlear implant trialMay 14, 2025 | investing.comEnvoy Medical (COCH) Receives a Buy from Northland SecuritiesApril 24, 2025 | markets.businessinsider.comSee More Headlines COCH Stock Analysis - Frequently Asked Questions How have COCH shares performed this year? Envoy Medical's stock was trading at $1.43 at the beginning of 2025. Since then, COCH shares have increased by 4.9% and is now trading at $1.50. View the best growth stocks for 2025 here. How were Envoy Medical's earnings last quarter? Envoy Medical, Inc. (NASDAQ:COCH) announced its earnings results on Friday, March, 28th. The company reported ($0.45) earnings per share for the quarter, missing analysts' consensus estimates of ($0.33) by $0.12. The business had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.07 million. How do I buy shares of Envoy Medical? Shares of COCH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Envoy Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Envoy Medical investors own include Avino Silver & Gold Mines (ASM), Tesla (TSLA), XPeng (XPEV), AbCellera Biologics (ABCL), AutoZone (AZO), CrowdStrike (CRWD) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings3/28/2025Today7/01/2025Next Earnings (Estimated)8/11/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:COCH CIK1840877 Webwww.envoymedical.com Phone877-900-3277FaxN/AEmployees34Year FoundedN/APrice Target and Rating Average Stock Price Target$9.25 High Stock Price Target$9.50 Low Stock Price Target$9.00 Potential Upside/Downside+551.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$20.80 million Net Margins-10,656.13% Pretax Margin-9,208.96% Return on EquityN/A Return on Assets-237.44% Debt Debt-to-Equity RatioN/A Current Ratio1.09 Quick Ratio0.88 Sales & Book Value Annual Sales$212 thousand Price / Sales142.85 Cash FlowN/A Price / Cash FlowN/A Book Value($0.88) per share Price / Book-1.61Miscellaneous Outstanding Shares21,327,000Free Float8,765,000Market Cap$30.28 million OptionableNot Optionable Beta2.29 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free Report This page (NASDAQ:COCH) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredFine. Don’t believe me. They called me an alarmist... When in 2010 I said America’s debt was out of control. When I warned it w...Porter & Company | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Envoy Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Envoy Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.